Postmarketing Study Of Lybrel In Relation To Venous Thromboembolism.

Trial Profile

Postmarketing Study Of Lybrel In Relation To Venous Thromboembolism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2013

At a glance

  • Drugs Ethinylestradiol; Ethinylestradiol/levonorgestrel; Ethinylestradiol/norethisterone; Oral contraceptives
  • Indications Pregnancy
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 25 Jul 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
    • 01 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top